Unveiling the Molecular Repertoire of Akkermansia muciniphila : From Mechanistic Insights to Precision Biotherapeutics
Journal of Microbiology and Biotechnology · 01.06.2026 · 36
DOI: 10.4014/jmb.2604.04017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 01.06.2026. Verfasst von Tae-Hwan Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Microbiome. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea, Korea Research Institute of Bioscience and Biotechnology.
Abstract (Originalsprache)
The gut microbiota has been established as a cornerstone of host physiological homeostasis. Among its diverse members, Akkermansia muciniphila has gained significant prominence as a premier next-generation probiotic candidate, demonstrating broad efficacy in alleviating metabolic disorders, inflammatory bowel disease, and neurodegenerative conditions. While early research primarily focused on clinical correlations and population abundance, recent scientific paradigms have shifted toward elucidating the underlying molecular mechanisms and specific host-microbe interactions. This review provides a comprehensive synthesis of recent breakthroughs in identifying A. muciniphila-derived bioactive effectors, including structural components, secreted enzymes, and signaling peptides. We examine how these molecular postbiotics orchestrate host health by reinforcing intestinal barrier integrity, modulating systemic immune responses, and reprogramming the tumor microenvironment. By integrating these multifaceted modes of action into a unified framework, we evaluate the therapeutic potential of both live bacteria and cell-free derivatives. Furthermore, we address the critical challenges regarding strain-specific efficacy and ecological impacts, providing a strategic roadmap for the clinical translation of A. muciniphila into the next frontier of precision microbiome medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea.
- Department of Biology Education, Chonnam National University, Gwangju 61186, Republic of Korea.
- Microbiome Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Korea Research Institute of Bioscience and Biotechnology
Zitieren
APA
Kim, T. H., Kim, S. M., & Kim, M. H. (2026). Unveiling the Molecular Repertoire of Akkermansia muciniphila : From Mechanistic Insights to Precision Biotherapeutics. Journal of Microbiology and Biotechnology, 36. https://doi.org/10.4014/jmb.2604.04017
Vancouver
Kim TH, Kim SM, Kim MH. Unveiling the Molecular Repertoire of Akkermansia muciniphila : From Mechanistic Insights to Precision Biotherapeutics. Journal of Microbiology and Biotechnology. 2026;36. doi:10.4014/jmb.2604.04017
BibTeX
@article{Kim2026,
author = {Kim, Tae-Hwan and Kim, Su-Man and Kim, Myung Hee},
title = {Unveiling the Molecular Repertoire of Akkermansia muciniphila : From Mechanistic Insights to Precision Biotherapeutics},
journal = {Journal of Microbiology and Biotechnology},
year = {2026},
volume = {36},
doi = {10.4014/jmb.2604.04017}
}
EUVIMED